We are live on
!
Find out more
SL
Siren LLC Portfolio holdings
AUM
$3.61B
1-Year Est. Return
203.3%
This Fund
S&P 500
This Quarter
Est. Return
+22.99%
1 Year Est. Return
+203.3%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2B
AUM Growth
–
Cap. Flow
+$1.96B
Cap. Flow
% of AUM
97.94%
Top 10 Holdings %
Top 10 Hldgs %
41.25%
Holding
112
New
112
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kymera Therapeutics
KYMR
|
+$131M |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$101M |
| 3 |
Scholar Rock
SRRK
|
+$98.9M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$80.3M |
| 5 |
BCAX
Bicara Therapeutics
BCAX
|
+$78.4M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 93.5% |
| 2 | Technology | 2.87% |
| 3 | Communication Services | 1.83% |
| 4 | Consumer Discretionary | 0.77% |
| 5 | Real Estate | 0.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RAPP
51
Rapport Therapeutics
RAPP
$2.18B
| $7.87M | 0.39% |
+384,197
| New | +$8.26M |
|
52
Neurogene
NGNE
$712M
| $7.38M | 0.37% |
+175,898
| New | +$6.82M |
|
|
GBIO
53
DELISTED
Generation Bio
GBIO
| $7.37M | 0.37% |
+298,273
| New | +$7.89M |
|
54
IHS Holding
IHS
$2.81B
| $7.05M | 0.35% |
+2,357,520
| New | +$7.25M |
|
55
CrowdStrike
CRWD
$218B
| $7.01M | 0.35% |
+100,000
| New | +$7.1M |
|
|
VIGL
56
DELISTED
Vigil Neuroscience
VIGL
| $6.77M | 0.34% |
+1,991,038
| New | +$7.38M |
|
57
Foghorn Therapeutics
FHTX
$360M
| $6.71M | 0.34% |
+720,720
| New | +$5.22M |
|
58
ServiceNow
NOW
$129B
| $6.71M | 0.34% |
+37,500
| New | +$6.17M |
|
59
Amazon
AMZN
$2.96T
| $6.47M | 0.32% |
+34,750
| New | +$6.34M |
|
|
BIOA
60
BioAge Labs
BIOA
$538M
| $6.24M | 0.31% |
+300,000
| New | +$6.01M |
|
61
NVIDIA
NVDA
$5.42T
| $5.94M | 0.3% |
+48,932
| New | +$5.78M |
|
|
SYRS
62
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.56M | 0.28% |
+2,587,372
| New | +$9.29M |
|
63
NovoCure
NVCR
$1.91B
| $5.48M | 0.27% |
+350,884
| New | +$6.36M |
|
64
Lexeo Therapeutics
LXEO
$378M
| $5.46M | 0.27% |
+603,435
| New | +$7.2M |
|
65
Pinduoduo
PDD
$131B
| $5.45M | 0.27% |
+40,401
| New | +$4.96M |
|
|
KLRS
66
Kalaris Therapeutics
KLRS
$96.8M
| $5.33M | 0.27% |
+286,833
| New | +$5.02M |
|
67
Black Diamond Therapeutics
BDTX
$112M
| $4.55M | 0.23% |
+1,046,517
| New | +$5.69M |
|
68
Alto Neuroscience
ANRO
$1.11B
| $4.48M | 0.22% |
+391,406
| New | +$4.79M |
|
69
Dynatrace
DT
$14.2B
| $4.42M | 0.22% |
+82,729
| New | +$3.94M |
|
70
IonQ
IONQ
$16.6B
| $4.37M | 0.22% |
+500,000
| New | +$3.81M |
|
71
TSMC
TSM
$2.18T
| $4.34M | 0.22% |
+25,000
| New | +$4.26M |
|
|
AGEN
72
Agenus
AGEN
$290M
| $4.25M | 0.21% |
+775,000
| New | +$5.8M |
|
73
Datadog
DDOG
$84B
| $3.79M | 0.19% |
+32,925
| New | +$3.85M |
|
74
ADC Therapeutics
ADCT
$144M
| $3.66M | 0.18% |
+1,163,461
| New | +$3.67M |
|
75
Sea Limited
SE
$69.5B
| $3.54M | 0.18% |
+37,500
| New | +$2.83M |
|
Similar funds
SCM
ACM
GCM
VI
BPS
VPC
WWA
OCM
Siren LLC's Q3 2024 Portfolio in Review
Q3 2024 is the first quarter with a 13F filing on record for Siren LLC, which disclosed 112 positions worth $2B. Its ten largest holdings account for 41% of the portfolio.
Its largest position is Kymera Therapeutics: 2,969,733 shares worth $141M.
By sector, the portfolio is most concentrated in Healthcare at 93% of assets, followed by Technology and Communication Services.
- Siren LLC's largest Q3 2024 buy was Kymera Therapeutics: 2,969,733 shares worth $141M.
- Siren LLC's ten largest holdings make up 41% of its $2B portfolio in Q3 2024.
- Siren LLC disclosed 112 positions in Q3 2024, its first 13F filing on record.
Based on Siren LLC's 13F filing for Q3 2024, filed 13 Nov 2024.